CDER Ad Division To Create Separate Biologics Review Group

FDA's drug advertising division will establish a separate team to oversee the review of ads for biologics as part of the CBER/CDER consolidation, Division of Drug Marketing, Advertising & Communications Director Tom Abrams said at the Drug Information Association annual meeting in San Antonio June 17